Circular No. (33/2026) - Recall of Affected Batch of Paclitaxel AqVida
30 Jul 2026
Reference: CIR-2026-00000109
To all Health facilities and healthcare practitioners in Dubai's private health sector
Referring to the above subject, DHA notifies all health facilities regarding the circulars issued by the Emirates Drug Establishment for perusal and adherence to what is stated.
Circular No. (33/2026) - Recall of Affected Batch of Paclitaxel AqVida
Thanks in advance for your good co-operation
Drug Control Section
Health Regulation Sector
Do you find this Content helpful?